Cargando…
Cancer stem cells and microglia in the processes of glioblastoma multiforme invasive growth
The development of antitumor medication based on autologous stem cells is one of the most advanced methods in glioblastoma multiforme (GBM) treatment. However, there are no objective criteria for evaluating the effectiveness of this medication on cancer stem cells (CSCs). One possible criterion coul...
Autores principales: | Bryukhovetskiy, Igor, Manzhulo, Igor, Mischenko, Polina, Milkina, Elena, Dyuizen, Inessa, Bryukhovetskiy, Andrey, Khotimchenko, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998210/ https://www.ncbi.nlm.nih.gov/pubmed/27602106 http://dx.doi.org/10.3892/ol.2016.4886 |
Ejemplares similares
-
Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme
por: Bryukhovetskiy, Igor S., et al.
Publicado: (2016) -
Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
por: Bryukhovetskiy, Igor, et al.
Publicado: (2017) -
Interaction of hematopoietic CD34(+) CD45(+) stem cells and cancer cells stimulated by TGF-β1 in a model of glioblastoma in vitro
por: Milkina, Elena, et al.
Publicado: (2018) -
Cell-based immunotherapy of glioblastoma multiforme
por: Bryukhovetskiy, Igor
Publicado: (2022) -
Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro
por: BRYUKHOVETSKIY, IGOR STEPANOVICH, et al.
Publicado: (2015)